These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33766372)

  • 1. Crystal and molecular structure of V-amylose complexed with ibuprofen.
    Le CAK; Ogawa Y; Dubreuil F; Grimaud F; Mazeau K; Ziegler GR; Tanwar S; Nishiyama Y; Potocki-Veronese G; Choisnard L; Wouessidjewe D; Putaux JL
    Carbohydr Polym; 2021 Jun; 261():117885. PubMed ID: 33766372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single crystals of V-amylose complexed with alpha-naphthol.
    Cardoso MB; Putaux JL; Nishiyama Y; Helbert W; Hÿtch M; Silveira NP; Chanzy H
    Biomacromolecules; 2007 Apr; 8(4):1319-26. PubMed ID: 17348704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single crystals of V amylose complexed with n-butanol or n-pentanol: structural features and properties.
    Helbert W; Chanzy H
    Int J Biol Macromol; 1994 Aug; 16(4):207-13. PubMed ID: 7848968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single crystals of V amylose complexed with glycerol.
    Hulleman SH; Helbert W; Chanzy H
    Int J Biol Macromol; 1996 Feb; 18(1-2):115-22. PubMed ID: 8852760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single crystals of V amylose complexed with isopropanol and acetone.
    Buléon A; Delage MM; Brisson J; Chanzy H
    Int J Biol Macromol; 1990 Feb; 12(1):25-33. PubMed ID: 2083238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of amylose complexes with small ligands.
    Nuessli J; Putaux JL; Bail PL; Buléon A
    Int J Biol Macromol; 2003 Dec; 33(4-5):227-34. PubMed ID: 14607368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facile synthesis and structural characterization of amylose-Fatty Acid inclusion complexes.
    Cao Z; Woortman AJ; Rudolf P; Loos K
    Macromol Biosci; 2015 May; 15(5):691-7. PubMed ID: 25641740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The crystal and molecular structure of VH amylose by electron diffraction analysis.
    Brisson J; Chanzy H; Winter WT
    Int J Biol Macromol; 1991 Feb; 13(1):31-9. PubMed ID: 2059581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A-type crystals from dilute solutions of short amylose chains.
    Montesanti N; Véronèse G; Buléon A; Escalier PC; Kitamura S; Putaux JL
    Biomacromolecules; 2010 Nov; 11(11):3049-58. PubMed ID: 20873857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism of crystalline complexes of V-amylose with fatty acids.
    Le CA; Choisnard L; Wouessidjewe D; Putaux JL
    Int J Biol Macromol; 2018 Nov; 119():555-564. PubMed ID: 30059739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermal expansion behavior of A- and B-type amylose crystals in the low-temperature region.
    Kobayashi K; Kimura S; Naito PK; Togawa E; Wada M
    Carbohydr Polym; 2015 Oct; 131():399-406. PubMed ID: 26256200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solvent-responsive behavior of inclusion complexes between amylose and polytetrahydrofuran.
    Rachmawati R; Woortman AJ; Loos K
    Macromol Biosci; 2014 Jan; 14(1):56-68. PubMed ID: 23996920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization and in vivo evaluation of pharmacological activity of different crystal forms of ibuprofen.
    Li Y; Yao F; Shang C; Ren F; Zhang J; Li Y; Yang G; Lin R; Wang W
    Pak J Pharm Sci; 2019 Sep; 32(5):2139-2147. PubMed ID: 31813880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial salt screening procedures for manufacturing ibuprofen.
    Lee T; Wang YW
    Drug Dev Ind Pharm; 2009 May; 35(5):555-67. PubMed ID: 19005918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization, and evaluation of physicochemical properties of different crystalline forms of ibuprofen.
    Khan GM; Jiabi Z
    Drug Dev Ind Pharm; 1998 May; 24(5):463-71. PubMed ID: 9876609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological and structural features of amylose spherocrystals of A-type.
    Helbert W; Chanzy H; Planchot V; Buléon A; Colonna P
    Int J Biol Macromol; 1993 Jun; 15(3):183-7. PubMed ID: 8329330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amorphous magnesium carbonate nanoparticles with strong stabilizing capability for amorphous ibuprofen.
    Yang J; Alvebratt C; Lu X; Bergström CAS; Strømme M; Welch K
    Int J Pharm; 2018 Sep; 548(1):515-521. PubMed ID: 29981897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of spring dextrin impact on amylose retrogradation.
    Xu J; Zhao W; Ning Y; Jin Z; Xu B; Xu X
    J Agric Food Chem; 2012 May; 60(19):4970-6. PubMed ID: 22536814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aqueous dissolution of crystalline and amorphous amylose-alcohol complexes.
    Whittam MA; Orford PD; Ring SG; Clark SA; Parker ML; Cairns P; Miles MJ
    Int J Biol Macromol; 1989 Dec; 11(6):339-44. PubMed ID: 2489102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the wetting and dissolution of ibuprofen using solventless co-milling.
    Varghese S; Ghoroi C
    Int J Pharm; 2017 Nov; 533(1):145-155. PubMed ID: 28951348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.